Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Al Musella"'
Autor:
Mark Shapiro, Timothy J. Stuhlmiller, Bryan Federowicz, William Hoos, Asher Wasserman, Glenn Kramer, Zach Kaufman, Don Chuyka, Julie C. Friedland, Bill Mahoney, Al Musella, Mika Newton, Zachary Osking, J. M. Tenenbaum, Kenny K. Wong, Santosh Kesari, Jeff Shrager
PurposexDECIDE is a clinical decision support system, accessed through a web portal and powered by a “Human-AI Team”, that offers oncology healthcare providers a set of treatment options personalized for their cancer patients, and provides outcom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::374dcf63d1efa3e19fd9463a66190636
https://doi.org/10.1101/2022.03.14.22272390
https://doi.org/10.1101/2022.03.14.22272390
Publikováno v:
Artificial Intelligence in Medicine. 135:102450
Publikováno v:
Patient preference and adherence
Al Musella,1 Ralph DeVitto,2 Matt Anthony,3 Dellann Elliott Mydland4 1The Musella Foundation for Brain Tumor Research & Information, Inc, Hewlett, NY, USA; 2American Brain Tumor Association, Chicago, IL, USA; 3Head for the Cure Foundation, Kansas Cit
Autor:
Nicholas Blondin, Santosh Kesari, Zachary Osking, Mark Shapiro, Julie Friedland, Ekokobe Fonkem, Matthew Warner, Asher Wasserman, Eric T. Wong, Al Musella, Timothy J. Stuhlmiller, Bryan Federowicz, Jeff Shrager
Publikováno v:
Neuro-Oncology. 23:vi113-vi113
xCures operates a direct-to-patient, real-world evidence platform for decentralized clinical research. The platform leverages a nationwide observational research protocol (XCELSIOR, NCT03793088) to aggregate, normalize, and analyze N-of-1 clinical ou
Autor:
Kathy Oliver, Kay Verble, Amanda Bates, Minesh P. Mehta, Marta Penas-Prado, Patrick Y. Wen, Brian M. Alexander, Martin J. van den Bent, Michael A. Vogelbaum, Shawn L. Hervey-Jumper, David A. Reardon, Bret E Friday, David Sandak, Thomas Halkin, Ugonma Chukwueke, Al Musella, Michael Weller, Jose Pablo Leone, Eudocia Q. Lee, David R. Macdonald, John de Groot, David Arons, Nicole Willmarth, Terri Armstrong, Nan Lin, Sarah C. Gaffey, Lisa Doherty, Evanthia Galanis, Maryam Fouladi, Solmaz Sahebjam, Susan M. Chang
Publikováno v:
Neuro-Oncology, 21(9), 1100-1117. Oxford University Press
Neuro-oncology, vol 21, iss 9
Neuro Oncol
Neuro-oncology, vol 21, iss 9
Neuro Oncol
Many factors contribute to the poor survival of malignant brain tumor patients, some of which are not easily remedied. However, one contributor to the lack of progress that may be modifiable is poor clinical trial accrual. Surveys of brain tumor pati
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Martin Bendszus, Caroline Chung, W. K. Alfred Yung, Daniel P. Barboriak, Michael V. Knopp, Elizabeth R. Gerstner, Dewen Yang, Evanthia Galanis, Chas Haynes, Bradley J. Erickson, David Arons, Timothy F. Cloughesy, Andrew Whitney, Mark R. Gilbert, Jayashree Kalpathy-Cramer, Paula M. Jacobs, Al Musella, Whitney B. Pope, Gregory V. Goldmacher, Patrick Y. Wen, Sarah J. Nelson, Brian M. Alexander, Marion Smits, Soonme Cha, Jerrold L. Boxerman, David Sandak, Michael A. Vogelbaum, Wolfgang Wick, Benjamin M. Ellingson, Lalitha K. Shankar, Susan M. Chang, Max Wallace, Martin J. van den Bent, Michael Weller, Ann E Kingston
Publikováno v:
Neuro-Oncology, 17(9), 1188-1198. Oxford University Press
A recent joint meeting was held on January 30, 2014, with the US Food and Drug Administration (FDA), National Cancer Institute (NCI), clinical scientists, imaging experts, pharmaceutical and biotech companies, clinical trials cooperative groups, and
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.